Top

BMC Cancer

Published in:

Open Access 01-12-2018 | Research article

The impact of the social environment on Zambian cervical cancer prevention practices

Authors: Anayawa Nyambe, Jarl K. Kampen, Stridutt K. Baboo, Guido Van Hal

Published in: BMC Cancer | Issue 1/2018

Abstract

Background

Cervical cancer which is preventable by screening and vaccination is the most common cancer in Zambia among both the female and male population. In this article we aim to determine how the key players of the sociocultural and political environment recognize cervical cancer as a public health problem and therefore impact the provision of cervical cancer prevention services (screening and vaccination).

Methods

Qualitative data in the form of interviews with stakeholders (health care providers, teachers and religious leaders), special interest groups (advocacy groups and non-governmental organizations) and policy makers, was collected as part of a mixed methods study from February to May 2016.

Results

The views expressed by the respondents were coded into predetermined themes (cervical cancer in general, screening, vaccination) and an organizational chart of the administration of cervical cancer prevention services in Zambia was developed.

Conclusions

It is evident that the Zambian cervical cancer prevention system has targeted several areas and multiple sectors of society to reduce cervical cancer cases. However, awareness, knowledge, social support and facilities are factors that can be improved.

Available only for authorised users

Bruni, L., Barrionuevo-Rosas, L., Albero G., Serrano, B., Mena, M., Gómez, D., Muñoz, J., Bosch, F.X., de Sanjosé S. (2017). Human papillomavirus and related diseases in Zambia. Summary report. ICO/IARC information Centre on papillomavirus and Cancer (HPV information Centre).

Cervical Cancer Prevention Programme Zambia. (2011). Peer education training manual: cervical Cancer. Zambia.

Centers for Disease Control and Prevention, (2013). National Breast and Cervical Cancer Early Detection Program, Retrieved from http://www.cdc.gov/cancer/nbccedp/sem.htm, on March 27, 2015.

Chirwa S, Mwanahamuntu M, Kapambwe S, Mkumba G, Stringer J, Sahasrabuddhe V, Parham G. Myths and misconceptions about cervical cancer among Zambian women: rapid assessment by peer educators. Glob Health Promot. 2010;17(2_suppl):47–50 https://doi.org/10.1177/1757975910363938.CrossRef

Cunningham MS, Skrastins E, Fitzpatrick R, Jindal P, Oneko O, Yeates K, et al. Cervical cancer screening and HPV vaccine acceptability among rural and urban women in Kilimanjaro region, Tanzania. BMJ Open. 2015;5(3):e005828.CrossRef

Flay BR, Snyder F, Petraitis J. The theory of triadic influence. In: DiClemente RJ, Kegler MC, Crosby RA, editors. Emerging theories in health promotion practice and research (second ed). New York: Jossey-Bass; 2009. p. 451–510.

Gu C, Chan CWH, Chow KM, Yang S, Luo Y, Cheng H, Wang H. Understanding the cervical screening behaviour of Chinese women: the role of health care system and health professions. Appl Nurs Res. 2018;39:58–64 https://doi.org/10.1016/j.apnr.2017.09.009.CrossRef

Liu FW, Vwalika B, Hacker MR, Allen S, Awtrey CS. Cervical cancer and HPV vaccination: knowledge and attitudes of adult women in Lusaka, Zambia. J Vaccines & Vaccination. 2012;3(138):6816.

McLeroy KR, Bibeau D, Steckler A, Glanz K. Ecological perspective on health promotion programs. Health Educ Q. 1998;15(4):351–77.CrossRef

10.

Milimo MM, Daka E, Sikuyuba L, Nyirenda J, Ngoma C. Knowledge and attitudes of parents/guardians towards uptake of human papilloma virus vaccine in preventing cervical cancer among girls in Zambia. Journal of Medicine and Medical Sciences. 2015;3(3):084–91.

11.

Ministry of Community Development, Mother and Child Health. (n.d.). Guidelines for Vaccinators Human Papillomavirus Vaccination to Prevent Cervical Cancer, Zambia.

12.

Ministry of Health. (2016). National Cancer Control Strategic Plan 2016-2021, Zambia.

13.

Mulenga, E.C., Mulenga, Y., Makoane, C.B., & Yeboah, K. (2012). Scalable and cost effective approach to providing cervical Cancer screening and treatment in the Zambia defense forces: a promising practice document. Zambia: PCI.

14.

Mwanahamuntu MH, Sahasrabuddhe VV, Kapambwe S, Pfaendler KS, Chibwesha C, Mkumba G, Stringer JS. Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the cervical Cancer prevention program in Zambia. PLoS Med. 2011;8(5):e1001032.CrossRef

15.

Nyambe A, Van Hal G, Kampen JK. Screening and vaccination as determined by the social ecological model and the theory of triadic influence: a systematic review. BMC Public Health. 2016;16(1). https://doi.org/10.1186/s12889-016-3802-6.

16.

Parham GP, Mwanahammuntu M, Pfaendler K, Mkumba G, Sahasrabuddhe VV, Hicks ML, Weltyg E, Stringer JSA. Building a cervical cancer prevention program into the HIV care and treatment infrastructure in Zambia. Oppor Infect, Cancers Coinfect. From the Ground Up. 2004;2:419–35.

17.

Parham GP, Mwanahamuntu MH, Pfaendler KS, Sahasrabuddhe VV, Myung D, Mkumba G, Stringer JSA. eC3-a modern telecommunications matrix for cervical Cancer prevention in Zambia. J. Low. Genit. Tract Dis. 2010;14(3):167–73 https://doi.org/10.1097/LGT.0b013e3181cd6d5e.CrossRef

18.

Patton MQ. Qualitative research and evaluation of methods, third edition. California: Sage Publications Inc.; 2002. p. 104–7. ISBN 0-7619-1971-6.

19.

Petraitis J, Flay BR, Miller TQ, Torpy EJ, Greiner B. Illicit substance use among adolescents: a matrix of prospective predictors. Substance Use & Misuse. 1998;33(13):2561–604.CrossRef

20.

Pinder LF, Mwanahamuntu MH, Chisele S, Chirwa S, Matambo J, Parham GP. Village based screening: a cervical cancer prevention service platform for rural women in Zambia. Gynecol Oncol. 2017;145(64):–65.

21.

Planned Parenthood Association of Zambia. (n.d.). What we do: Projects. [Web log post]. Retrieved October 13, 2017, from https://ppazambia.wordpress.com/what-we-do/projects/

22.

Simaubi MH, Ngoma MC. Cervical cancer awareness and uptake of pap-smear services among women above 18 years of age. Med. J. Zambia. 2013;40(1):19–23.

23.

Stop Cervical Cancer in Africa (2012). The 6th Stop Cervical Cancer in Africa Conference, A New Era in Cervical Cancer Prevention, Conference Report, 22–24 July, Zambia.

24.

Turner, P. & Turner, S. (2009). Virtual Reality 13: 171. https://doi.org/10.1007/s10055-009-0117-2

25.

White HL, Mulambia C, Sinkala M, Mwanahamuntu MH, Parham GP, Moneyham L, Chamot E. “Worse than HIV” or “not as serious as other diseases”? Conceptualization of cervical cancer among newly screened women in Zambia. Soc Sci Med. 2012;74(10):1486–93 https://doi.org/10.1016/j.socscimed.2012.01.028.CrossRef

26.

World Health Organization. (2015). Human papilloma virus vaccine introduced in Zambia. Retrieved November 29, 2016, from http://www.afro.who.int/en/zambia/press-materials/item/5609-human-papilloma-virus-hpv-vaccine-introduced-in-zambia.html.

27.

World Health Organization Regional Office for Africa. (2012). Addressing the challenges of Women’s health in Africa: report of the commission on Women’s health in the African region, AFRO library cataloguing-in-publication data.

Title: The impact of the social environment on Zambian cervical cancer prevention practices
Authors: Anayawa Nyambe
Jarl K. Kampen
Stridutt K. Baboo
Guido Van Hal
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-018-5164-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2018

Study protocol for a controlled trial of an eHealth system utilising patient reported outcome measures for personalised treatment and care: PROMPT-Care 2.0

Validation of Quality of Life Instruments for Cancer Patients – Colorectal Cancer (QLICP-CR) in patients with colorectal cancer in Northeast China

Quality of life of survivors of malignant pleural mesothelioma in Japan: a cross sectional study

Impact of body mass index on surgical outcomes of gastric cancer

Radiotherapy related skin toxicity (RAREST-01): Mepitel® film versus standard care in patients with locally advanced head-and-neck cancer

EGF/EGFR upregulates and cooperates with Netrin-4 to protect glioblastoma cells from DNA damage-induced senescence

Keynote webinar | Spotlight on antibody–drug conjugates in cancer